United States

Bio Rad Laboratories Inc (BIOb.N)

BIOb.N on New York Stock Exchange

9:32am EST
Change (% chg)

$-0.75 (-0.40%)
Prev Close
Day's High
Day's Low
Avg. Vol
52-wk High
52-wk Low


Chart for BIOb.N


Bio-Rad Laboratories, Inc. (Bio-Rad) is a manufacturer and distributor of life science research and clinical diagnostics products. The Company manufactures and supplies the life science research, healthcare, analytical chemistry and other markets with a range of products and systems used to separate complex chemical and... (more)


Beta: 0.89
Market Cap(Mil.): $5,530.62
Shares Outstanding(Mil.): 29.42
Dividend: --
Yield (%): --


  BIOb.N Industry Sector
P/E (TTM): 56.59 33.71 30.46
EPS (TTM): 3.32 -- --
ROI: 2.88 13.21 14.82
ROE: 3.83 16.83 16.24

BRIEF-Bio-Rad to acquire Raindance Technologies, Droplet Intellectual Property

* Bio-Rad to acquire Raindance Technologies and Droplet Intellectual Property

Jan 16 2017

BRIEF-Bio-Rad Q3 earnings per share $0.62

* Bio-Rad reports third-quarter currency-neutral revenue growth of 9.1 percent

Nov 01 2016

BRIEF-Bio Rad Laboratories receives clearance from FDA for IH-1000 blood typing instrument

* Has received clearance from U.S. Food and Drug Administration for its IH-1000 blood typing instrument Source text for Eikon: Further company coverage:

Oct 24 2016

BRIEF-Bio Rad Laboratories reports Q2 profit $0.61 per share

* Second-Quarter reported revenues were $516.8 million, an increase of 2.1 percent

Aug 03 2016

Earnings vs. Estimates